Adlai Nortye：AN9025 仍需人体验证 (NASDAQ:ANL)
· seekingalpha.com
Adlai Nortye 的 AN9025 已开始给药，但有效性数据要到 2027 年才会公布。点击此处阅读关于 ANL 股票的最新分析。
Adlai Nortye Ltd. ( ANL ) is an oncology firm that currently develops three main candidates, which are AN9025, AN8025, and AN4035. All three assets now have Pha...